Trial · NCT04658420
A Single Ketamine Infusion Combined With Music for Suicidal Ideation
NCT04658420, Phase 2, Unknown, The University of Texas Health Science Center at Tyler
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Single Ketamine Infusion Combined With Music for Suicidal Ideation. Trials, record NCT04658420. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04658420
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Single Ketamine Infusion Combined With Music for Suicidal Ideation
- NCT number
- NCT04658420
- Status
- Unknown
- Phases
- Phase 2
- Enrollment
- 200 participants, estimated
- Lead sponsor
- The University of Texas Health Science Center at Tyler
- Conditions
- Suicidal Ideation, Depressive Episode
- Interventions
- Ketamine Hydrochloride, Music
- First posted
- 2020-12-08
- Last updated
- 2021-05-07
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Scale for Suicide Ideation (SSI) | 4 weeks | Clinician administered scale. Score range 0-38. Higher scores are indicative of increased suicidal ideation. The primary efficacy evaluation for each panel will be the change in SSI total score from baseline, prior to the first IV ketamine dose, to 4 weeks after IV ketamine treatment. 25 % reduction in score will be deemed treatment response, 50% reduction will be determined to be treatment remission. |
| Secondary | Montgomery Asberg Depression Rating Scale (MADRS) | 4 weeks | Clinician administered depression rating scale. Score range= 0-60, higher scores are indicative of more severe depression. 50% score reduction is defined as response, 25% or less improvement in MADRS will be considered a non response. |
| Secondary | World Health Organization Quality of life Scale (WHOQOL-BREF) | 4 weeks | Score range- 0-100. Quality of life at study entry and every week. Higher scores are indicative of higher quality of life |
| Secondary | Quick Inventory of Depressive Symptomatology (QIDS SR-16) | 4 weeks | Self report measure of depression. Range 1-27, with higher scores indicative of more severe depression |
| Secondary | Time of hospitalization | 4 weeks | Average days of hospitalization between treatment groups |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers16
The papers the trial lists on ClinicalTrials.gov.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| KL2TR003168 | Institutional Career Development Core | MILLER, CHARLES C | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON | NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES | 2019 to 2023 |
Source NIH RePORTER
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04658420
GET https://conductscience.org/api/trials/v1/NCT04658420/registered